A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation
Active, not recruiting · Not applicable · NCT04147884
Conditions: Mitral Regurgitation Functional, Mitral Valve Disease, Cardiovascular Diseases
At a glance
- Research payments reported, 2025
- $2,533
- U.S. investigators named
- 2
- Sites paid
- 2
- Planned or actual enrollment
- 4
About the trial
- Sponsor
- Boston Scientific Corporation
- Tested
- Millipede Transcatheter Annuloplasty Ring System (Millipede System) (device)
- Dates
- Started 2019-11-13; completion 2026-11
- Results posted
- Not yet
To evaluate the feasibility and safety of the Millipede Transcatheter Annuloplasty Ring System in subjects with functional mitral regurgitation
From ClinicalTrials.gov, last updated 2026-10-23. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Boston Scientific Corporation reported $2,533 in research payments for this study in 2025 (2 payments).
Products named: Clinical Trial Product
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Thomas E. Waggoner I, D.O. Interventional Cardiology · Tucson, AZ
- Susheel K. Kodali, M.D. Interventional Cardiology · New York, NY
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Trustees of Columbia Univ in The City of Ny $1,883
- Tmc Healthcare $650
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.